Disaccharides are well-known reagents to protect biostructures like proteins and phospholipid-based liposomes during freezing and drying. We have investigated the ability of the two disaccharides trehalose and sucrose to stabilize a novel, non-phospholipid-based liposomal adjuvant composed of the cationic dimethyldioctadecylammonium (DDA) and trehalose 6,6′-dibehenate (TDB) upon freeze-drying. The liposomes were freeze-dried using a human dose concentration containing 2.5 mg/ml DDA and 0.5 mg/ml TDB with varying concentrations of the two sugars. The influence on particle size upon rehydration was investigated using photon correlation spectroscopy (PCS) and the gel to fluid phase transition was examined by differential scanning calorimetry (DSC). Data revealed that concentrations above 211 mM trehalose protected and preserved DDA/ TDB during freeze-drying, and the liposomes were readily rehydrated. Sucrose was less efficient as a stabilizer and had to be used in concentrations above 396 mM in order to obtain the same effect. Immunization of mice with the tuberculosis vaccine candidate Ag85B-ESAT-6 in combination with the trehalose stabilized adjuvant showed that freeze-dried DDA/TDB liposomes retained their ability to stimulate both a strong cell-mediated immune response and an antibody response. These findings show that trehalose at isotonic concentrations protects cationic DDA/ TDB-liposomes during freeze-drying. Since this is not the case for liposomes based on DDA solely, we suggest that the protection is facilitated via direct interaction with the headgroup of TDB and a kosmotropic effect, whereas direct interaction with DDA plays a minor role.
Introduction
Vaccines are widely regarded as highly cost-effective tools for improving health and have for the last decades had a major impact on public health [1] . Despite the existence of an impressive range of vaccines, the developing world in particular remain vulnerable to infectious diseases and world wide 2.7 million people die every year due to vaccine-preventable diseases [2] . A major reason is inadequate infrastructure and a lack of effective distribution chains, which results in an annual loss of millions of vaccine doses. Since most vaccines are not thermo-stable, the distribution of vaccines requires "cold chains" with functioning freezers and refrigerators, good infrastructure and reliable transport. It is therefore essential early in the development of vaccines against third world diseases to incorporate vaccine stability as a key success criterion. In this regard, developing thermo-stable vaccines may obviate the need for the "cold chain". One approach is freezedrying and this technique has been used successfully for vaccines against e.g. measles, yellow fever, meningitis, tuberculosis (TB) and smallpox.
One attractive vaccination strategy is based on the subunit technology, where well-defined and highly pure antigens produced recombinantly can induce a protective immune response against pathogens. However, as these antigens are not by themselves immunogenic, they rely on adjuvants to elicit the appropriate immune response. There are only few adjuvants approved for human use and most of them, like the Aluminum salts, only induce humoral immune responses. Therefore, the development of new adjuvants, capable of inducing various types of immune responses, e.g. cell mediated as well as mixed cell mediated and humoral immune responses, has been an international research priority for important global health emergencies like TB [3] [4] [5] , malaria [6] and HIV [7] . A novel adjuvant consisting of the cationic surfactant dimethyldioctadecylammonium bromide (DDA) and α,α′-trehalose 6,6′-dibehenate (TDB) promotes a strong cell mediated immune response and a humoral immune response [8] , which is essential for the induction of protective immunity against most diseases. Together these two components form multivesicular liposomes, which due to the cationic nature of DDA can adsorb most antigens on their surface [8] . In combination with the tuberculosis vaccine antigen Ag85B-ESAT-6, DDA/TDB has promoted strong T H 1 biased cellular immune responses and efficient immunity against TB in mice [9] , guinea pigs and nonhuman primates (unpublished data). Furthermore, DDA/TDB has proven to be a very useful adjuvant for the malaria antigens GLURP and MSP-3 in preclinical studies (Theisen, M., personal communication) and now faces clinical trials with these antigens.
Liposomes are difficult to suspend after freeze-drying due to destruction of the lipid bilayer upon removal of water [10] . Addition of lyoprotectants to the liposome formulation is necessary to avoid this membrane-damaging effect. Especially sugars like trehalose and sucrose have been shown to be effective in stabilizing lipid membranes as well as proteins upon freeze-drying [11] [12] [13] .
In general, to preserve membrane structures during freezedrying, it is important to avoid fusion and leakage of the liposomes [13, 14] . Freezing and dehydration of liposomes result in fusion between neighbouring bilayers and the formation of larger aggregates. By adding a vitrifier, such as trehalose or sucrose, to the liposomes and keeping the freeze-drying temperature below the glass transition temperature (T g ) of the vitrifier, the fusion can be avoided as the vitrification prevents the liposomes from interacting with each other [15] [16] [17] [18] .
Generally, most liposomes consisting of unsaturated lipids have gel-to-liquid crystalline phase transition temperatures (T m ) below 0°C. During freeze-drying the T m can increase with as much as 80°C [14, 19] . As a result, freeze-dried liposomes based on unsaturated lipids undergo a gel to liquid phase transition accompanied by leakage during rehydration. To avoid this phase transition, T m of the liposomes in the dry state should be depressed. By adding disaccharides like trehalose or sucrose T m is lowered. One hypothesis for this reduction of T m is that it is a result of the vitrification process, which allows the membranes to remain in the fluid phase at water concentrations that would normally lead to gel state phase transition [16, 20, 21] . Another hypothesis explains this depression of T m as a result of direct interaction, where hydrogen bond formation between the hydroxyl groups of the disaccharides and the polar head groups of the lipids results in spacing between the lipids in the dry state similar to that of the hydrated lipid [15, 18, 19, [22] [23] [24] . This spacing causes a more disordered membrane packing resulting in a reduction of T m . Trehalose has been suggested to exist in two distinct populations in the dry lipid/trehalose mixturesone that is directly interacting with lipid head groups and thereby replacing water, and another population in the bulk glassy state [13] .
Liposomes based on saturated lipids have higher T m values than liposomes based on unsaturated lipids. As a result no leakage is expected because they do not undergo a phase transition during drying and rehydration. Vitrification alone should therefore be sufficient for preservation of these liposomes [15] . Liposomes based on DDA/TDB consist of saturated lipids and undergo their main phase transition at 42.4°C [8] . This is well above the rehydration temperature, which diminishes the risk of leakage during the freeze-drying process. We therefore hypothesize that disaccharides in the bulk glassy state can stabilize DDA/TDB liposomes during freezedrying.
To our knowledge, so far very little has been reported on the ability of sugars to stabilize liposomes based on other components than phospholipids. This paper describes the ability of sucrose and trehalose to protect freeze-dried, cationic liposomes based on a human dose concentration of DDA/TDB. The influence of freeze-drying on particle size and the gel-toliquid phase transition temperature after rehydration was analysed to investigate if the formulation could be reconstituted without physico-chemical changes and to elucidate the function of the lyoprotectors. Finally, we tested whether the freeze-dried vesicles retained their adjuvant effect in vivo upon rehydration.
Materials and methods

Materials
Dimethyldioctadecylammonium (DDA) bromide and α,α′-trehalose 6,6′-dibehenate (TDB) were obtained from Avanti Polar Lipids (Alabaster, AL). The purity of the compounds was N99% by HPLC. Methanol (extra pure) and chloroform (extra pure) were purchased from Merck (Darmstadt, Germany). Tris base (99%) was obtained from Sigma-Aldrich (St. Louis, MO). Purified water of Milli-Q quality was used to prepare all buffers. D(+) trehalose dihydrate (≥99%), and sucrose (≥99%) were obtained from Sigma-Aldrich (Brøndby, Denmark). Ag85B-ESAT-6 was produced as previously described [8] .
Preparation of lyophilized adjuvant formulations
The adjuvant was prepared by the thin film method as described previously [8] . Briefly, weighed amounts of DDA and TDB (5:1 w/w) were dissolved in chloroform/methanol (9:1 v/v) and the organic solvent was removed using a gentle stream of N 2 , forming a thin lipid film on the bottom of the test vial. The lipid film was dried overnight under vacuum to remove trace amounts of the organic solvent.
Lyoprotector solutions were prepared by mixing various amounts of trehalose or sucrose with 10 mM Tris-buffer (pH 7.4). The lipid films were hydrated in the lyoprotector solutions to a final concentration of 2.5 mg/ml DDA and 0.5 mg/ml TDB by heating for 20 min at 10°C above the main phase transition temperature of DDA (T m ≈47°C) [25] .
Aliquots (800 μl) of the formulations were transferred to 3 ml injection vials (Forma Vitrum, St. Gallen, Switzerland). The freezing-and primary drying temperature was selected to be 10°C below the T g of the aqueous solutions of trehalose and sucrose which is approximately − 30°C according the literature [26] [27] [28] . The formulations were therefore frozen to − 40°C at a cooling rate of 0.70°C/min on the temperature controlled shelf in a Christ DELTA 2-24 LSC freeze-dryer (Martin Christ, Osterode am Harz, Germany). The shelf temperature was kept at − 40°C for 15 min before the primary drying was initiated by lowering the vacuum to 0.340 mBar. The shelf temperature was maintained at − 40°C for 22 h, and then gradually raised to +20°C over a period of 13 h. A final drying step was done at 0.021 mBar for 10 h. All formulations for analysis in the rehydrated form were hydrated to a final concentration equal to the expected human concentration of 2.5 mg/ml DDA and 0.5 mg/ml TDB.
Size determination
The size of DDA/TDB liposomes was determined by dynamic light scattering using the photon correlation spectroscopy (PCS) technique. The measurements were performed on undiluted samples (n = 3) at 25°C using a Malvern NanoZS (Malvern Instruments, Worcestershire, UK) equipped with a 633-nm laser and 173°detection optics. Malvern DTS v.4.20 software (Malvern Instruments, Worcestershire, UK) was used for data acquisition and analysis. A polystyrene size standard (220 ± 6 nm, Duke scientific corp., Duke, NC) was used to verify the performance of the instrument. All measurements were adjusted according to sample viscosity, which was determined using a TA Instruments CSL 2 100 Carri-Med Rheometer with a 6-cm steal cone (TA Instruments, Surrey, England) and TA Instruments Rheology Solution CSL V1.1.6 and DATA V1.1.6 (TA Instruments, Surrey, England) software for data acquisition and analysis, respectively. Statistical calculations were done by oneway ANOVA and means comparison was done using Tukey's test. A significance level of 0.01 was chosen due to the polydispersity of the formulations.
Phase transition temperatures
The gel-to-liquid phase transition temperature of the undiluted vesicles in suspension was determined using differential scanning calorimetry (DSC). Thermograms were obtained as described previously [8] using a MicroCal VP-DSC MicroCalorimeter (MicroCal LLC, Northampton, USA), scanning at a rate of 30°C/h from 25°C to 60°C [8] . VPViewer 2000 and Origin® 7 scientific plotting software (OriginLab, Northampton, USA) were used for data analysis. The first of three scans of each sample (n = 3) was used for data analysis. Statistical calculations were done by one-way ANOVA at 0.05 significance level and means comparison using Tukey's test.
Immunization of mice
Female C57BL/6 mice, 6 to 12 weeks old, were obtained from Harlan Scandinavia (Allerød, Denmark). The vaccines were prepared by mixing the freshly prepared or freeze-dried, resuspended DDA/TDB with TB antigen Ag85B-ESAT6. The final Ag85B-ESAT-6 concentration was 10 μg/ml, and the final concentration of DDA and TDB was 1.25 and 0.25 mg/ml respectively for all formulations. Mice were immunized subcutaneously (s.c.) at the base of the tails two times with a 2-week interval between the immunizations (0.2 ml/dose).
Spleens were harvested 14 days after the last immunization. Individual splenocyte cultures (n = 3) were obtained by passage of spleens through a metal mesh followed by washing twice in RPMI (Gibco Invitrogen, Carlsbad, CA). Splenocyte cultures were grown in round-bottomed microtiter plates (Nunc, Roskilde, Denmark) as described previously [8] .
Immunological analysis
The number of interferon-γ (IFN)-γ, interleukin (IL)-5 and IL-4 producing cells was determined by ELISPOT. To detect the number of IFN-γ producing cells, 96-well PVDF filter plates (MAHA S45 10 Millipore Corp., MA, USA) were coated over-night at 4°C with 4 μg/ml IFN-γ capture Ab (BD Biosciences, San Diego, CA) in PBS. Plates were washed five times and blocked with RPMI medium containing 10% FCS (Gibco Invitrogen, Carlsbad, CA). Splenocytes from individual mice were added and incubated for 48 h at 37°C, 5% CO 2 with 5 μg of Ag85B-ESAT-6. Plates were subsequently washed with 0.05% Tween in PBS and incubated with 1.25 μg/ml of anti-IFN-γ-biotin secondary Ab (BD Biosciences, San Diego, CA) diluted in PBS for 2 h. Secreted IFN-γ was measured using an alkaline phosphatase-conjugated streptavidin Ab (DAKO, Denmark) and developed with a BCIP/NBT substrate (Sigma, St. Louis, MO, USA). Spots were counted using an automated ELISPOT Reader System and software (AID, Strassberg, Germany).
ELISPOT to detect IL-5 producing cells was performed as described for IFN-γ. Reagents used were 2 μg/ml of capture IL-5 Ab (BD Biosciences, San Diego, CA), and 1 μg/ml of anti-IL5-biotin secondary Ab (BD Biosciences, San Diego, CA). ELISPOT to detect IL-4 producing cells was performed as described for IFN-γ except the plates used were 96-well BDTM 51-2447kc filter plates (BD Biosciences, San Diego, CA) and the incubation time was 24 h instead of 48 h. Reagents used were 2 μg/ml of capture IL-4 Ab (BD Biosciences, San Diego, CA), and 1 μg/ml of anti-IL4-biotin secondary Ab (BD Biosciences, San Diego, CA).
Statistical calculations were done by one-way ANOVA at 0.05 significance level and means comparison using Tukey's test.
Antibody titers
Antibody titres were determined by ELISA as previously described [29] . Plates for ELISA (Nunc maxisorp, Roskilde, Denmark) were coated with Ag85B-ESAT-6 (0.05 μg /well) in PBS, and individual mouse sera from 3 mice per group were analysed in duplicate in 5-fold dilutions. Horse radish peroxidase-conjugated secondary antibodies (rabbit anti-mouse IgG1 and IgG2a, Zymed, USA) diluted 1/2000 in PBS containing 1% BSA were added, and Ag85B-ESAT-6 specific antibodies were detected by TMB substrate (KemEn-Tec, Copenhagen, Denmark) as described by the manufacturer. The absorbance values were plotted as a function of the reciprocal dilution of serum samples and the antibody titres were defined as the serum dilution which gives an absorbance value of A 492 = 1.00 in the parallel portion of the curves as previously described [30] . For serum samples where the antibody titration curves were below this value, the titer was defined as below the dilution 20 (b20). Statistical calculations were done by one-way ANOVA at 0.05 significance level and means comparison using Tukey's test.
Results and discussion
Evaluation of visual appearance of DDA/TDB after freeze-drying and after rehydration
In the present study DDA/TDB vesicles were freeze-dried in single dosed vials in the presence of sucrose or trehalose at various concentrations. The freeze-dried formulations were examined by visual inspection. A uniform cake matrix was obtained after freeze-drying of DDA/TDB vesicles in the presence of trehalose or sucrose at concentrations ranging from 132 to 396 mM. At lower concentrations, a collapse of the cake was observed indicating that these concentrations of sugars were insufficient to prevent aggregation of DDA/TDB. This collapse is illustrated in Fig. 1 with pictures of cakes containing 264 mM and 67 mM trehalose. The collapse was most pronounced for the formulations containing sucrose (data not shown).
Formulations containing 211 mM trehalose and 396 mM sucrose and more were readily rehydrated, and the process occurred within 10 min with no visual sign of aggregates. Formulations with lower concentrations of sugar were rehydrated more slowly and the formulations with the lowest concentrations showed signs of aggregates even hours after rehydration (data not shown).
These results suggest that with sufficient amounts of trehalose and sucrose it is possible to freeze-dry DDA/TDB liposomes and create a stable dry cake. Furthermore they show that insufficient amounts of cryo-/lyoprotector result in slow rehydration.
A successful lyophilization should enable the product to rapidly reabsorb solvent and restore the substance to its original state. To examine whether the physicochemical characteristics of DDA/TDB vesicles upon freeze-drying were preserved, particle size measurements and thermal analyses were carried out.
Effect of cryo-/lyoprotectors and freeze-drying on particle size
The particle size of DDA/TDB vesicles was analysed to determine which sugar concentration was sufficient to preserve the average particle size upon freeze-drying. The average particle size of DDA/TDB without lyoprotector was 425 ± 18 nm (Fig. 2) , which is in accordance with earlier results [8] . Addition of different concentrations of trehalose and sucrose resulted in a significantly increased average particle size (507 ± 22 nm and 504 ± 36 nm respectively). This increase may be explained by an increased hydrodynamic diameter of the liposomes due to coating of the vesicle surface with the sugars through hydrogen bonding with TDB, but it could also be caused by the formation of more multivesicular vesicles upon addition of the sugars. The increased particle size did not affect the visual appearance.
The average particle size of the freeze-dried formulations was measured 10 min after rehydration. As illustrated in Fig. 2 , the formulations with 211 mM trehalose and above had regained their normal non-lyophilized particle size after 10 min of rehydration (no significant difference at F = 0.01). This was not the case for the formulations with lower concentrations of trehalose indicating that these liposomes were not fully rehydrated or that the membrane structures were not preserved during the freeze-drying process. Only at a concentration of 396 mM sucrose (the highest concentration of sucrose analysed in this study), rehydration of the DDA/TDB took place within 10 min. It was not possible to measure the particle size of the freeze-dried formulations containing less than 132 mM sugar due to aggregation. For these formulations, not even 24 h of rehydration resulted in a normal particle size, suggesting that aggregation is irreversible (data not shown).
Since DDA/TDB liposomes used in this study is a polydisperse formulation, it was important to analyse if any changes in the particle size distribution could be detected. As illustrated for DDA/TDB with 264 mM trehalose in Fig. 3 (left) the sizeto-volume distribution pattern with three distinguishable peaks did not change (no statistical analysis performed) suggesting that the general size-to-volume distribution pattern was preserved upon freeze-drying despite the slight increase in average particle size. These results apply to formulations containing 211 mM and 396 mM trehalose as well (data not shown). Freshly prepared formulations containing 396 mM sucrose were found to be more mono-disperse than DDA/TDB without any sugar. However, the formulation containing 396 mM sucrose had a particle size distribution pattern similar to the DDA/TDB without sugar, the only difference being a larger proportion of liposomes in the 100-nm range (Fig. 3  right) . The reason for this difference is unknown and has to be investigated further.
The results thus show that at trehalose concentrations equal to 211 mM and above, the formulation can be reconstituted within 10 min with unchanged average as well as distribution of particle size, whereas sucrose only preserves the particle size at the highest concentration tested (396 mM). The results also before (open symbols) and after (closed symbols) freeze-drying. It was not possible to measure the particle size of the formulations containing less than 132 mM sugar due to aggregation (mean ± SD, n = 3). Fig. 1 . The freeze-dried cakes collapsed when freeze-drying with less than 132 mM trehalose. This is illustrated here with cakes formed in the presence of 264 mM (left) and 67 mM trehalose (right). confirm the conclusion from the visual inspections, that much more sucrose than trehalose is needed to obtain a quick rehydration after freeze-drying.
Effect of the cryo-/lyoprotectors on the thermotropic phase behaviour of DDA/TDB before freeze-drying
The thermotropic phase behaviour of DDA/TDB vesicles in the presence of trehalose or sucrose was determined before freeze-drying to investigate the effect of the sugars on the liposome dispersions. The thermograms obtained are shown in Fig. 4 . T m for DDA/TDB was observed at 42.62 ± 0.02°C, which is in accordance with earlier reports [8] . The addition of trehalose increased T m to 43.02 ± 0.08°C. There was no apparent difference between T m of the formulations containing different concentrations of trehalose. Addition of sucrose did not affect the main gel-to-liquid phase transition temperature of DDA/TDB. At 132 mM trehalose and above, a shoulder was observed on the high temperature side of the peak, which developed into a distinct peak at 48.68°C with 396 mM trehalose. The same pattern was observed with sucrose, though not so pronounced.
The small increase in T m for the formulations containing trehalose and the shoulder developing on the high temperature side of the peak could be explained by direct interaction [31] [32] [33] [34] [35] [36] [37] . Direct interaction of trehalose with the polar head-group of the lipids could cause the formation of a depletion layer around the vesicles, in which the concentration of water is lower than in the bulk phase. However, as the polar head-groups of DDA do not contain any free electrons at pH 7.4, the possibility of hydrogen bonding between the sugars and DDA is excluded. This suggests that the sugars do not exert any influence on the vesicle membranes through direct interaction with DDA.
The polar head-groups of TDB, on the other hand, consist of trehalose, with hydroxyl groups available for hydrogen bonding. DDA/TDB liposomes would therefore have this sugar available on the membrane surface for interaction with kosmotropic molecules like trehalose and sucrose. The kosmotropic effect can cause a de-structuring of the H-bond network of bulk water, which affects the dynamic properties of water and reduces the amount of water in the solvation layer surrounding the vesicle membranes [22, [38] [39] [40] . This could cause the T m of the liposome membrane to change due to lower flexibility and higher thermal stability and explain the shoulder on the high temperature side of the peak [22] . The gel-to-fluid phase transition temperature for DDA vesicles has been determined previously to be 47.20°C [8] . Another explanation for the shoulder on the high temperature side of the peak could therefore be that a phase separation between DDA and TDB results in local domains with higher concentrations of highly ordered DDA with elevated phase transition temperatures. This automatically implies other regions with higher local concentrations of TDB. According to Davidsen et al. [8] this phase separation would lead to a lowering of the gel-to-fluid phase transition of these areas. No reduction of T m was observed suggesting that phase separation cannot explain the shoulder on the high temperature side of the peak. More investigations are required to explain this behaviour further.
Effect of the cryo-/lyoprotectors on the thermotropic phase behaviour of DDA/TDB after freeze-drying
The thermotropic phase behaviour of the same DDA/TDB formulations after freeze-drying with different concentrations of sugars was determined 10 min after rehydration. Overall it was not possible to obtain a phase behaviour completely similar to the phase behaviour before freeze-drying, even at sugar concentrations where the particle size distribution was preserved. Fig. 5A illustrates how the shoulder appearing at approximately 48°C in the freshly prepared liposomes containing 264 mM trehalose developed into a distinct peak after freeze-drying. This could indicate that the physical appearance of the liposomes was retained during freeze-drying, but that the intra-molecular dispersion and/or the interaction with the surrounding media had changed.
As illustrated in Fig. 6 , freeze-dried formulations with trehalose concentrations below 211 mM (A) and sucrose concentrations below 264 mM (B) showed an exothermal peak at 42°C right before the endothermal peak. This peak was reduced at higher sugar concentrations and disappeared for the formulations containing more than 211 mM trehalose or 396 mM sucrose. Since the enthalpy of the endothermal peaks was lower compared to before freeze-drying for these formulations (data not shown), there is reason to believe that the exothermal process is still occurring at the time of measurement. At temperatures below T m , the membrane has a low permeability resulting in a slow diffusion of water into the core of the liposomes. The exothermal process could therefore be explained by increased diffusion of water across the lipid bilayer around the main transition temperature.
To support this hypothesis, the effect of rehydration time was investigated for two selected trehalose concentrations (132 and 264 mM). Increasing the rehydration time resulted in an enlargement of the enthalpy in both cases, as illustrated in Fig.  7A and B. For the formulation containing 132 mM trehalose the exothermal peak at 42°C almost disappeared after 24 h, whereas the peak at 48°C did not change, the latter being the case for formulations with both 132 and 264 mM trehalose. The gel-to-liquid phase transition changed only slightly over time for the formulation containing 264 mM trehalose. After 6 h, a peak similar to that observed before freeze drying was detected at 43°C. There was no difference between the results after 6 and 24 h, suggesting that the liposomes were maximally hydrated with the amount of water available (800 μl). These results support the hypothesis that the exothermal peak observed at 42°C immediately after rehydration of the formulations containing low concentrations of trehalose, is caused by hydration of liposomes not yet hydrated when the scan is initiated. It also demonstrates that the liposomes are almost fully hydrated after 10 min in the formulation containing 264 mM trehalose. The reason for the continuous presence of the peak at 48°C and the inability to regain the same thermotropic phase behaviour as before freeze-drying by enhancing the hydration time, could thus be explained by shortage of water.
This hypothesis was investigated by rehydrating DDA/TDB containing 264 mM in two (1600 μl) and four times (3200 μl) the normal hydration volume. As illustrated in Fig. 8 the peak at 48°C was reduced with double hydration volume, and four times the normal volume made the peak disappear. This suggests that the normal hydration volume is insufficient for complete rehydration. DDA/TDB formulations consist predominantly of unilamellar vesicles, but with a population of giant multivesicular vesicles [8] . The observed peak at 48°C could thus be due to limited hydration of the small vesicles entrapped inside larger liposomes. Another explanation for the peak at 48°C could be that the freeze-drying causes phase separation in the bilayer, resulting in highly ordered DDA domains, which are difficult to rehydrate. Since the particle size distribution is conserved upon freeze-drying and rehydration, the incomplete rehydration cannot be caused by formation of larger aggregates. Further investigations are necessary to verify the reason for the peak observed at 48°C.
The results from this study show that sucrose is needed in higher concentrations than trehalose to protect DDA/TDB during freeze-drying and to maintain a similar gel-to-liquid phase transition pattern after rehydration. This is in accordance with other studies [41] and could be explained by a stronger interaction between the lipid membrane and trehalose than with sucrose [33, 42] . Another reason could be the larger hydration volume of trehalose compared to sucrose making it a better kosmotrope [43] . During freezing and drying this in turn leads to minimized damage by water crystallization [44] [45] [46] [47] . A final explanation could be the high T g of trehalose in the dry state compared to other sugars [16, 48] making it a better vitrifier as it is less prone to crystallization than many other sugars [16] . Crystallization of the sugars could cause a lowered T g due to residual water, but this would also make the freeze-dried cake collapse. Since no collapse was observed in formulations with more than 132 mM sugar, residual water is not believed to cause crystallization. Furthermore, since crystallization of the sugars is a slow process below T g , there is no reason to believe that trehalose should be better to protect DDA/TDB during freezedrying, because of its abilities as a vitrifier. It is therefore unlikely that the superior effect of trehalose compared to sucrose is due to its vitrifying effects. In this case we do also not consider direct interaction with the main component DDA to be the major reason for the protective effect of sucrose and trehalose. The beneficial effect of trehalose compared to sucrose could on the other hand be due to its quality as a kosmotrope and its stronger direct interaction with TDB.
3.5. Importance of the presence of TDB in the liposomes during freeze-drying with trehalose as cryo-/lyoprotector
The afore-mentioned results suggest that direct interaction between the sugars and TDB plays an important role during freeze-drying of DDA/TDB. To investigate this further, liposomes based on DDA with 264 mM trehalose were freeze-dried under the same conditions as DDA/TDB with 264 mM trehalose and analysed by PCS and DSC. The average particle size of DDA without lyoprotector was 467 ± 45 nm (results not shown), which is in accordance with earlier results [8] . Trehalose did not affect the particle size of DDA liposomes before freeze-drying significantly (493 ± 32 nm) (results not shown). This could indicate that the observed increase in particle size of DDA/TDB in the presence of sugars is related to the presence of TDB.
It was not possible to measure the particle size ten min after rehydration of freeze-dried DDA due to profound aggregation (data not shown). This indicates that the presence of TDB is essential for the function of trehalose to protect the DDA liposomes during freeze-drying.
Differential scanning heat capacity curves were obtained on pure DDA and DDA with 264 mM trehalose to investigate if the shoulder on the high temperature side of the peak detected in DDA/TDB with similar concentrations of trehalose was due to direct kosmotropic interaction between the sugars and TDB. As illustrated in Fig. 5B the thermotropic phase behaviour of DDA is characterized by one sharp, well-defined endothermal peak with T m ≈ 47.13°C. This is in accordance with earlier results [8] . Addition of 264 mM trehalose caused a shift in T m to 46.53°C and a small broadening of the phase transition peak. This shift towards a lower temperature was not observed with DDA/TDB upon addition of trehalose. The lowering of the phase transition temperature could be explained by an interaction between DDA and trehalose that is currently investigated further.
No shoulder was observed at the high temperature side of the peak of freshly prepared DDA as for DDA/TDB (Figs. 4A and  5A ). This supports the theory mentioned previously, that trehalose interacts directly with TDB but not with DDA, and therefore only lowers the water content in the solvation layer of the vehicles containing TDB resulting in a higher phasetransition temperature. The fact that the phase transition peak observed for DDA is very narrow around 47°C opposes the theory that the shoulder observed with DDA/TDB at high concentrations of sugar could be due to DDA-rich regions caused by phase separation, since the latter is very broad and continues up to 50°C.
Rehydration of the freeze-dried DDA vehicles caused the formulation to aggregate. The phase behaviour of DDA upon rehydration was characterized by an elevation and broadening of the phase transition temperature. The broad phase transition revealed two peaks; a small peak with a maximum at 46.76°C and a main peak with maximum at 48.87°C. The smaller peak is coherent with the peak for a fully hydrated DDA lipid bilayer, whereas T m for the main peak is coherent with the one detected for DDA/TDB upon freeze-drying (Fig. 5) . This, and the fact that freeze-dried DDA was poorly rehydrated, suggests that the peak around 48°C is due to incomplete rehydration rather than phase separation.
Immunological activity of freeze-dried DDA/TDB
To make sure that the freeze-drying did not influence the adjuvant effect of DDA/TDB, this was analysed in an animal model. Mice were immunized with the Ag85B-ESAT-6 antigen mixed with either freeze-dried, rehydrated DDA/TDB vesicles containing 264 mM trehalose or freshly prepared DDA/TDB vesicles for comparison. On the basis of the physicochemical data of DDA/TDB before and after freeze-drying, it was decided to use a formulation containing 264 mM trehalose in the animal study. Since sucrose only fulfilled the criteria of rehydration within 10 min at hypertonic concentrations (N264 mM), formulations containing sucrose were not included in the study.
It has been established previously that DDA/TDB liposomes induce both a strong, specific Th1 type immune-response characterized by production of high levels of IFN-γ and at the same time a humoral immune response with production of IgG1 and IgG2a antibodies [8] . Both the freshly prepared liposomes and the freeze-dried formulation were able to induce a high frequency of IFN-γ producing cells, whereas low levels of IL-4 and IL-5 producing cells were seen in both cases, as shown by ELISPOT analysis (Table 1 ). There was no statistical significant difference between the responses induced by the freshly prepared and the freeze dried formulations.
The ability of freeze-dried DDA/TDB vesicles to induce an antibody response after immunization was investigated by measuring the levels of antigen-specific antibodies of the IgG1 and IgG2b isotypes. The results in Table 1 indicate that freezedrying of DDA/TDB had no influence on the levels of antigen specific antibodies nor did it affect the isotype distribution. Overall the immunological analyses demonstrated that freezedrying preserves the adjuvant effect of DDA/TDB and its ability to stimulate both a cell mediated immune response and an antibody response.
Conclusion
The data presented here prove that, in addition to its wellknown ability to protect liposomes based on phospholipids, trehalose is also able to protect cationic liposomes based on other lipids. The mechanism of action is not yet fully understood, but these data suggest that the direct interaction with TDB possibly plays a role, whereas the kosmotropic effect and vitrification of the sugars might be the main causes. We are currently investigating this issue further. Based on these physico-chemical and immunological data we have demonstrated that trehalose in concentrations from 211 mM protects a human dose of DDA/TDB during freeze-drying, enables rapid rehydration (within 10 min) and maintains the adjuvant effect of DDA/TDB. Therefore a freeze-dried formulation of DDA/TDB represents a strong adjuvant alternative for novel vaccines, where easy administration and thermostability are the key issues.
